Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04552509 · ClinicalTrials.gov registry record · NA

TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer

A NA study of Prostate Cancer, sponsored by Linda Chan, MD.

Recruiting
Registry status
NA
Development phase
167
Enrollment target
1
Study location

NCT04552509: Recruiting NA study of Prostate Cancer, sponsored by Linda Chan, MD.

NCT04552509 is a NA study of Prostate Cancer that is actively recruiting participants, run by Linda Chan, MD. The registered enrollment target is 167 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04552509, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Linda Chan, MD.

RECRUITING
Registry status
NA
Development phase
167 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of this evaluation is to see if this treatment will help patients with your condition and to evaluate the effect of this treatment on your quality of life over time. Radiosurgery is a non-invasive treatment technique used to treat tumors. Despite the word "surgery" in the name, the technology does not remove the tumor with a surgical knife. Instead, a focused, high-intensity beam of radiation targets the tumor, while minimizing dose to surrounding normal healthy tissue.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION Stereotactic Body Radiotherapy

Study Locations (1)

California

  • MemorialCare Saddleback Medical Center - Laguna Hills

Trial Details

FieldValue
Enrollment Target 167 participants
Start Date 2018-06-05
Est. Completion 2026-12-01
Phase NA

Sponsor

Linda Chan, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04552509

The ClinicalTrials.gov registry entry for NCT04552509 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Linda Chan, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.

NCT04552509 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04552509 about?

NCT04552509 is a clinical study titled "TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer". The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of t...

What is the current status of trial NCT04552509?

This trial is currently recruiting. It is a NA study. The enrollment target is 167 participants. The study started on 2018-06-05. Estimated completion is 2026-12-01.

What conditions does trial NCT04552509 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04552509?

The interventions under investigation include: Stereotactic Body Radiotherapy (RADIATION).

Who is sponsoring clinical trial NCT04552509?

This trial is sponsored by Linda Chan, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04552509 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.